| Financial Year |
March 31 2023 |
| Monetary Funds |
2,577,658,934.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,267,153.14 |
| Accounts Receivable |
1,545,520,220.66 |
| Advances to Suppliers |
13,442,203.32 |
| Other Receivables |
62,719,519.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
72,694,079.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
117,074,986.38 |
| Total Current Assets |
5,362,309,422.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,738,522.09 |
| Investment Properties |
-- |
| Fixed Assetes |
2,515,114,921.99 |
| Under-construction Projects |
192,092,263.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,991,810,495.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,724,976.40 |
| Deferred Income Tax Assets |
60,501,440.44 |
| Other Non-Current Assets |
17,057,777,449.71 |
| Sub-Total of Non-Current Assets |
22,995,130,764.04 |
| Total Assets |
28,357,440,186.20 |
| Short-Term Loans |
580,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,718,737,817.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,278,387.31 |
| Taxes Payable |
51,833,412.74 |
| Interest Payable |
-- |
| Dividend Payable |
8,822,500.00 |
| Other payables |
132,442,510.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,405,568,819.37 |
| Other Current Liabilities |
94,226,625.95 |
| Sub-Total of Current Liabilities |
5,125,382,282.42 |
| Long-term Loans |
12,941,412,322.80 |
| Bonds Payable |
998,541,191.29 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
113,486.67 |
| Deferred Income Tax Liabilities |
108,219,039.13 |
| Other Non-Current Liabilities |
1,185,612,410.54 |
| Sub-Total of Non-Current Liabilities |
15,513,779,037.78 |
| Total Liabilities |
20,639,161,320.20 |
| Paid-In Capital(Or Share Stock) |
974,684,488.00 |
| Capital Surplus |
3,861,399,602.55 |
| Surplus Reserve |
281,391,105.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,667,651,253.47 |
| Minority Stockholder's Interest |
879,176,611.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,839,102,254.46 |
| Owner's Equity（Stockholder's Equity） |
7,718,278,866.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,357,440,186.20 |
